Savaria (TSE:SIS) Price Target Raised to C$33.00 at Scotia

Savaria (TSE:SISFree Report) had its price target lifted by Scotia from C$30.00 to C$33.00 in a research report sent to investors on Thursday morning,BayStreet.CA reports. Scotia currently has a sector outperform rating on the stock.

A number of other research analysts have also issued reports on the company. TD Securities boosted their price objective on Savaria from C$27.00 to C$31.00 and gave the company a “buy” rating in a research report on Thursday, March 5th. Raymond James Financial boosted their price objective on Savaria from C$32.00 to C$33.00 and gave the company an “outperform” rating in a research report on Wednesday. National Bank Financial boosted their price objective on Savaria from C$30.00 to C$30.50 and gave the company an “outperform” rating in a research report on Friday, March 6th. TD boosted their price objective on Savaria from C$31.00 to C$35.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Scotiabank boosted their price objective on Savaria from C$29.00 to C$30.00 and gave the company an “outperform” rating in a research report on Friday, March 6th. Nine analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of C$32.61.

Get Our Latest Research Report on Savaria

Savaria Price Performance

Shares of SIS opened at C$28.59 on Thursday. The firm has a market cap of C$2.06 billion, a price-to-earnings ratio of 29.78, a PEG ratio of 42.72 and a beta of 0.86. The stock has a 50 day moving average of C$26.16 and a 200-day moving average of C$23.74. The company has a current ratio of 1.61, a quick ratio of 0.91 and a debt-to-equity ratio of 32.13. Savaria has a 52 week low of C$16.13 and a 52 week high of C$30.41.

Savaria (TSE:SISGet Free Report) last released its quarterly earnings data on Wednesday, March 4th. The company reported C$0.37 earnings per share (EPS) for the quarter. Savaria had a return on equity of 11.10% and a net margin of 7.53%.The business had revenue of C$241.78 million during the quarter. As a group, analysts forecast that Savaria will post 1.2048518 EPS for the current year.

Insiders Place Their Bets

In other Savaria news, insider Jean-Philippe De Montigny bought 2,420 shares of the business’s stock in a transaction on Friday, March 20th. The shares were purchased at an average price of C$25.50 per share, with a total value of C$61,710.00. Following the purchase, the insider directly owned 92,260 shares of the company’s stock, valued at approximately C$2,352,630. The trade was a 2.69% increase in their ownership of the stock. 17.45% of the stock is owned by insiders.

Savaria News Summary

Here are the key news stories impacting Savaria this week:

  • Positive Sentiment: Desjardins raised its price target to C$35.00 and kept a “buy” rating — about a 22.8% upside from current levels. BayStreet.CA
  • Positive Sentiment: Scotia raised its target to C$33.00 and set a “sector outperform” rating — ~15.7% implied upside. BayStreet.CA
  • Positive Sentiment: ATB Cormark Capital Markets bumped its target to C$35.00 and kept an “outperform” call — ~21.6% upside. BayStreet.CA
  • Positive Sentiment: Raymond James raised its target to C$33.00 and maintained an “outperform” rating — ~14.7% implied upside. BayStreet.CA
  • Positive Sentiment: TD increased its target to C$35.00 and kept a “buy” rating — ~21.6% upside; coverage also noted on TickerReport. BayStreet.CA TickerReport

About Savaria

(Get Free Report)

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

Featured Stories

Analyst Recommendations for Savaria (TSE:SIS)

Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.